Go Pro
→ Iran War Shock: What I Was Told In That Private Meeting (From Banyan Hill Publishing) (Ad)tc pixel Free HTGMQ Stock Alerts

HTG Molecular Diagnostics (HTGMQ) Competitors

Compare

HTGMQ vs. THMO, SXTPW, ACONW, DRTSW, and ALVOW

Should you buy HTG Molecular Diagnostics stock or one of its competitors? HTG Molecular Diagnostics's main competitors and comparable companies include ThermoGenesis (THMO), 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), Alpha Tau Medical (DRTSW), and Alvotech (ALVOW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does HTG Molecular Diagnostics compare to ThermoGenesis?

HTG Molecular Diagnostics (NASDAQ:HTGMQ) and ThermoGenesis (NASDAQ:THMO) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations.

5.8% of ThermoGenesis shares are owned by institutional investors. 2.6% of HTG Molecular Diagnostics shares are owned by company insiders. Comparatively, 78.0% of ThermoGenesis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

ThermoGenesis has higher revenue and earnings than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HTG Molecular Diagnostics$6.37M0.00-$21.59MN/AN/A
ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A

In the previous week, HTG Molecular Diagnostics' average media sentiment score of 0.00 equaled ThermoGenesis'average media sentiment score.

Company Overall Sentiment
HTG Molecular Diagnostics Neutral
ThermoGenesis Neutral

HTG Molecular Diagnostics has a beta of 3, indicating that its share price is 200% more volatile than the broader market. Comparatively, ThermoGenesis has a beta of 1.09, indicating that its share price is 9% more volatile than the broader market.

Company Net Margins Return on Equity Return on Assets
HTG Molecular DiagnosticsN/A N/A N/A
ThermoGenesis N/A N/A N/A

Summary

ThermoGenesis beats HTG Molecular Diagnostics on 5 of the 6 factors compared between the two stocks.

How does HTG Molecular Diagnostics compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, media sentiment, risk and dividends.

60 Degrees Pharmaceuticals has higher earnings, but lower revenue than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.11MN/AN/AN/AN/A
HTG Molecular Diagnostics$6.37M0.00-$21.59MN/AN/A

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
HTG Molecular Diagnostics N/A N/A N/A

In the previous week, 60 Degrees Pharmaceuticals had 3 more articles in the media than HTG Molecular Diagnostics. MarketBeat recorded 3 mentions for 60 Degrees Pharmaceuticals and 0 mentions for HTG Molecular Diagnostics. 60 Degrees Pharmaceuticals' average media sentiment score of 0.30 beat HTG Molecular Diagnostics' score of 0.00 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
60 Degrees Pharmaceuticals Neutral
HTG Molecular Diagnostics Neutral

Summary

60 Degrees Pharmaceuticals beats HTG Molecular Diagnostics on 2 of the 3 factors compared between the two stocks.

How does HTG Molecular Diagnostics compare to Aclarion?

Aclarion (NASDAQ:ACONW) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends, media sentiment and institutional ownership.

Aclarion has higher earnings, but lower revenue than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aclarion$83.77KN/AN/AN/AN/A
HTG Molecular Diagnostics$6.37M0.00-$21.59MN/AN/A

In the previous week, Aclarion had 2 more articles in the media than HTG Molecular Diagnostics. MarketBeat recorded 2 mentions for Aclarion and 0 mentions for HTG Molecular Diagnostics. Aclarion's average media sentiment score of 1.43 beat HTG Molecular Diagnostics' score of 0.00 indicating that Aclarion is being referred to more favorably in the media.

Company Overall Sentiment
Aclarion Positive
HTG Molecular Diagnostics Neutral

Company Net Margins Return on Equity Return on Assets
AclarionN/A N/A N/A
HTG Molecular Diagnostics N/A N/A N/A

Summary

Aclarion beats HTG Molecular Diagnostics on 2 of the 3 factors compared between the two stocks.

How does HTG Molecular Diagnostics compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTSW) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, media sentiment, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.

Alpha Tau Medical has higher earnings, but lower revenue than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/AN/AN/AN/A
HTG Molecular Diagnostics$6.37M0.00-$21.59MN/AN/A

In the previous week, Alpha Tau Medical had 2 more articles in the media than HTG Molecular Diagnostics. MarketBeat recorded 2 mentions for Alpha Tau Medical and 0 mentions for HTG Molecular Diagnostics. Alpha Tau Medical's average media sentiment score of 0.43 beat HTG Molecular Diagnostics' score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the media.

Company Overall Sentiment
Alpha Tau Medical Neutral
HTG Molecular Diagnostics Neutral

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A N/A N/A
HTG Molecular Diagnostics N/A N/A N/A

Summary

Alpha Tau Medical beats HTG Molecular Diagnostics on 2 of the 3 factors compared between the two stocks.

How does HTG Molecular Diagnostics compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, media sentiment, analyst recommendations, institutional ownership, risk, valuation and dividends.

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
HTG Molecular Diagnostics N/A N/A N/A

Alvotech has higher revenue and earnings than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$491.95MN/AN/AN/AN/A
HTG Molecular Diagnostics$6.37M0.00-$21.59MN/AN/A

In the previous week, Alvotech had 1 more articles in the media than HTG Molecular Diagnostics. MarketBeat recorded 1 mentions for Alvotech and 0 mentions for HTG Molecular Diagnostics. Alvotech's average media sentiment score of 1.87 beat HTG Molecular Diagnostics' score of 0.00 indicating that Alvotech is being referred to more favorably in the media.

Company Overall Sentiment
Alvotech Very Positive
HTG Molecular Diagnostics Neutral

Summary

Alvotech beats HTG Molecular Diagnostics on 3 of the 3 factors compared between the two stocks.

Get HTG Molecular Diagnostics News Delivered to You Automatically

Sign up to receive the latest news and ratings for HTGMQ and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HTGMQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HTGMQ vs. The Competition

Export
MetricHTG Molecular DiagnosticsAnalytical instruments IndustryHealthcare SectorNASDAQ Exchange
Market CapN/AN/A$7.16B$14.31B
Dividend YieldN/AN/A2.57%11.71%
P/E Ratio0.00N/A273.3025.37
Price / SalesN/A0.00617.1274.54
Price / CashN/AN/A28.4234.96
Price / BookN/AN/A10.426.24
Net Income-$21.59M-$21.59M$3.49B$358.08M

HTG Molecular Diagnostics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HTGMQ
HTG Molecular Diagnostics
N/AN/AN/AN/A$0.00$6.37MN/A90
THMO
ThermoGenesis
N/AN/AN/AN/A$1K$9.61MN/A40
SXTPW
60 Degrees Pharmaceuticals
N/A$0.03
flat		N/A-28.9%$0.00$1.11MN/A2
ACONW
Aclarion
N/A$0.03
+18.0%		N/A-17.9%$0.00$83.77KN/A7
DRTSW
Alpha Tau Medical
N/A$3.82
-4.6%		N/AN/A$0.00N/AN/A80

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:HTGMQ) was last updated on 9/15/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
These gold assets are priced for $1,800 gold [it's over $4,000]
Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...
Golden Portfolio | Sponsoredtc pixel